Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  1. Home
  2. Publications
  3. Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

Authors:
  • VBVandana Batra
    Vandana Batra
  • MSMinu Samanta
    Minu Samanta
  • MMMehran Makvandi
    Mehran Makvandi
  • DGDavid Groff
    David Groff
  • PMPaul Martorano
    Paul Martorano
  • JEJimmy Elias
    Jimmy Elias
  • PRPietro Ranieri
    Pietro Ranieri
  • MTMatthew Tsang
    Matthew Tsang
  • CHCatherine Hou
    Catherine Hou
  • YLYimei Li
    Yimei Li
  • BPBruce Pawel
    Bruce Pawel
  • DMDaniel Martinez
    Daniel Martinez

Open Access
Publisher website
Google Scholar
  • 31 March 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.22487928
Abstract
Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
Keywords
  • PRECLINICAL DEVELOPMENT
  • FIGURE FROM PRECLINICAL
  • SUPPLEMENTARY FIGURE
  • NEUROBLASTOMA
  • ALPHA
  • MABG
  • ASTATOBENZYLGUANIDINE
  • RADIOPHARMACEUTICAL
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.